Kaya Limited has announced a key senior management appointment, bringing aboard an experienced business leader to drive transformation initiatives. The healthcare company has strengthened its leadership team with the addition of a seasoned professional with extensive experience across multiple high-growth sectors.

Leadership Appointment Details

Kaya Limited has appointed Saurav Jha as Chief Business Transformation Officer effective December 22, 2025. The appointment was approved by the Board of Directors through a Circular Resolution dated December 17, 2025, marking a strategic addition to the company's senior management personnel.

Professional Background and Experience

Saurav Jha brings over 18 years of comprehensive experience across multiple business domains including business operations, category management, market expansion, retail and analytics. His career spans leadership roles in high-growth, technology-driven companies, positioning him well for the transformation role at Kaya Limited.

Jha's most recent position was at CaratLane. Prior to this, he worked with Urban Company, contributing to his diverse experience in technology-driven environments.

Career Highlights

Throughout his career, Jha has held leadership positions across several prominent organizations:

• CaratLane: Senior role
• Urban Company: Leadership role in business operations
• Other experiences in technology, analytics, and business services

Strategic Implications

The appointment of Jha as Chief Business Transformation Officer reflects Kaya Limited's focus on business evolution and growth strategies. His extensive experience in companies like CaratLane and Urban Company aligns with the transformation objectives of the healthcare services provider. The appointment, effective December 22, 2025, positions the company to leverage his expertise in driving strategic initiatives in the coming period.

Kaya Limited , a leading player in the skin and hair care industry, has reported its financial results for the second quarter of fiscal year 2026, revealing a mixed performance with revenue growth accompanied by an increased net loss.

Revenue Growth Amid Challenges

For the quarter ended September 30, 2025, Kaya Limited registered a consolidated revenue from operations of ₹538.50 crore, marking a modest increase from ₹525.20 crore in the corresponding quarter of the previous year. This 2.5% year-over-year growth indicates the company's ability to maintain its market presence despite challenging economic conditions.

Widening Net Loss

Despite the revenue growth, Kaya reported a consolidated net loss of ₹187.60 crore for Q2 FY26, compared to a loss of ₹156.70 crore in the same period last year. This represents a 19.7% increase in net loss, highlighting the ongoing financial pressures faced by the company.

Operational Highlights

Kaya's clinic business showed resilience, registering a 5% growth in revenue over Q2 FY25. The company's focus on key service categories yielded positive results:

• Acne & Scars services, aided by new service technology, witnessed a significant growth of 39% over Q2 FY25.
• Haircare services, supported by advanced diagnostic tools and enhanced customer journey, grew by 14%.
• Anti-Ageing services demonstrated strong growth of 11%.

The product business also performed well, registering an 18% growth over Q2 FY25, driven primarily by categories such as Nutraceutical, Anti-Ageing, and Sun Care.

Customer Satisfaction and Expansion

Kaya's commitment to customer experience was reflected in its Net Promoter Score (NPS), which touched 91 in Q2 FY26. The company also expanded its presence, launching two new clinics in Hyderabad during the quarter, both receiving high Google ratings.

Financial Position and Capital Infusion

The company's balance sheet as of September 30, 2025, showed total assets of ₹3,082.58 crore. However, Kaya faces challenges with a negative net worth and working capital position. The management remains optimistic about meeting future obligations, citing financial support from the promoter group and available funds.

To strengthen its financial position, Kaya raised ₹750 crore through a preferential issue of equity shares to Axana Estates LLP in August 2025. This capital infusion is earmarked for strategic expansion initiatives, including new clinics, relocation and renovation of existing clinics, and investment in new machines.

Conclusion

While Kaya Limited demonstrates growth in key operational areas and maintains customer satisfaction, the widening net loss presents ongoing challenges. The company's focus on expansion and strategic investments, supported by recent capital infusion, may play a crucial role in its efforts to improve its financial performance in the coming quarters.

Investors and stakeholders will be closely watching Kaya's performance in the subsequent quarters to assess the impact of these strategic initiatives on the company's financial health and market position.